Rare diseases
Investigational molecules
Locations
Back to Germany978 clinical trials in Frankfurt, Germany across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer
GermanyA study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
GermanyStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
GermanyRandomized trial of bupropion hydrochloride for fatigue in patients with long COVID (post‑COVID syndrome)
GermanyStudy of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma
GermanyA study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors
GermanyA study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer
GermanyA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
GermanyA study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis
GermanyComparing AZD5335 with mirvetuximab soravtansine or a drug combination in patients with platinum-resistant ovarian cancer
GermanyStudy to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis
GermanyA study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on hematologic malignancies and solid tumors, including innovative treatments for lymphoma, leukemia, and various gastrointestinal cancers.
Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Research initiatives examining treatments for inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis, with emphasis on long-term management approaches.
Focus on innovative therapeutic options for chronic inflammatory conditions.
Clinical investigations of treatments for rare conditions, including Von Willebrand Disease and Dravet Syndrome, exploring novel therapeutic approaches.
Development of targeted therapies for previously difficult-to-treat conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
